Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
ally bridge group
amicus therapeutics
approval
apremilast
base editing
big data analytics
bio
biogen
biome
blackrock
blueprint medicineas
boston
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
casdin capital
celgene
cervical cancer
clinical study
clinical trial
clinical trials
commissioner
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
What
bio
2
×
ipo
million
2
×
new
2
×
allogene
analysis
biotech
bring
cancer
company
crispr
develop
diseases
diversity
drug
employing
genetic
goldfinch
hot
immunotherapy
investors
juno
kidney
later
lead
medicines
nearly
raised
raises
remains
roundup
shares
snapped
studies
therapeutics
ticket
utero
years
Language
unset
Current search:
bio
×
new
×
million
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More